Home » Stocks » Cell MedX

Cell MedX Corp (CMXC)

Stock Price: $0.423 USD -0.027 (-6.00%)
Updated Oct 16, 2020 12:47 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 25.12M
Revenue (ttm) 76,990
Net Income (ttm) -1.05M
Shares Out 59.39M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 16, 2020
Last Price $0.423
Previous Close $0.450
Change ($) -0.027
Change (%) -6.00%
Day's Open 0.464
Day's Range 0.400 - 0.464
Day's Volume 43,929
52-Week Range 0.1645 - 0.7

More Stats

Market Cap 25.12M
Enterprise Value 25.59M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 59.39M
Float 26.95M
EPS (basic) -0.02
EPS (diluted) -0.02
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.13
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 326.29
PB Ratio n/a
Revenue 76,990
Operating Income -994,772
Net Income -1.05M
Free Cash Flow -893,365
Net Cash -471,421
Net Cash / Share -0.01
Gross Margin 111.17%
Operating Margin -1,292.08%
Profit Margin -1,362.00%
FCF Margin -1,160.36%
ROA -180.50%
ROE n/a
ROIC -174.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue0.10--0.010.040.04----
Revenue Growth----82.99%-14.23%-----
Gross Profit0.09---0.010.02----
Operating Income-1.04-0.67-1.54-1.22-2.10-0.94-0.02-0.01-0.02-0.01
Net Income-1.09-0.91-1.55-1.25-2.14-1.03-0.02-0.01-0.02-0.01
Shares Outstanding53.4844.2842.3136.8631.0031.0031.0031.0030.2730.00
Earnings Per Share-0.02-0.02-0.04-0.03-0.07-0.03----
Operating Cash Flow-0.93-0.31-0.45-0.75-0.42-0.32-0.01-0.01-0.02-0.02
Capital Expenditures----0.11-0.22-0.03----
Free Cash Flow-0.93-0.31-0.45-0.86-0.64-0.34-0.01-0.01-0.02-0.02
Cash & Equivalents0.050.060.010.070.030.000.000.010.020.00
Total Debt0.500.510.120.540.950.27----
Net Cash / Debt-0.46-0.45-0.11-0.47-0.92-0.270.000.010.020.00
Assets0.160.190.050.290.270.05-0.010.02-
Liabilities1.681.961.121.461.680.730.020.010.01-
Book Value-1.52-1.77-1.07-1.17-1.41-0.68-0.02-0.01-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cell MedX Corp
Country United States
CEO Frank E. Mcenulty

Stock Information

Ticker Symbol CMXC
Stock Exchange US OTC
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier OTCMKTS: CMXC

Description

Cell MedX, a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general relaxation and for the temporary relief of pain due to sore and/or aching muscles. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.